28 related articles for article (PubMed ID: 2714073)
1. Sensitization of Gram-Negative Bacteria to Aminoglycosides with 2-Aminoimidazole Adjuvants.
Crotteau AN; Hubble VB; Marrujo SA; Mattingly AE; Melander RJ; Melander C
Antibiotics (Basel); 2023 Oct; 12(11):. PubMed ID: 37998765
[TBL] [Abstract][Full Text] [Related]
2. Synergistic interaction between ofloxacin and cefotaxime against common clinical pathogens.
Jenkins SG; Lewis JW
Infection; 1995; 23(3):154-61. PubMed ID: 7499004
[TBL] [Abstract][Full Text] [Related]
3. Cefotaxime. An update of its pharmacology and therapeutic use.
Todd PA; Brogden RN
Drugs; 1990 Oct; 40(4):608-51. PubMed ID: 2083516
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of pharmacokinetics and serum bactericidal activity of ceftizoxime and cefotaxime.
Vallée F; LeBel M
Antimicrob Agents Chemother; 1991 Oct; 35(10):2057-64. PubMed ID: 1759827
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the in vitro action and interaction of cefotaxime and desacetylcefotaxime against clinical isolates of Bacteroides spp.
Aldridge KE
Diagn Microbiol Infect Dis; 1989; 12(1):45-50. PubMed ID: 2714072
[TBL] [Abstract][Full Text] [Related]
6. Synergistic interaction of cefotaxime and its metabolite desacetylcefotaxime demonstrated by drug-impregnated disks.
Stevens DL; Bergstrom R; Gibbons A
Diagn Microbiol Infect Dis; 1989; 12(1):73-80. PubMed ID: 2653715
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antibacterial interaction of cefotaxime and desacetylcefotaxime.
Molinari G; Saverino D; Paglia P; Debbia EA; Schito GC
J Chemother; 1991 Feb; 3(1):6-12. PubMed ID: 2019866
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the bactericidal activity of cefotaxime and desacetylcefotaxime alone and in combination against Bacteroides fragilis group organisms.
Aldridge KE; Weeks LS; Stratton CW; Sanders CV
Diagn Microbiol Infect Dis; 1989; 12(2):165-70. PubMed ID: 2752714
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of disk susceptibility testing of cefotaxime/desacetylcefotaxime.
Fuchs PC; Jones RN; Barry AL
Diagn Microbiol Infect Dis; 1989; 12(1):81-5. PubMed ID: 2714075
[TBL] [Abstract][Full Text] [Related]
10. Activity of cefotaxime/desacetylcefotaxime with two aminoglycosides against gram-negative pathogens: an example of interactive synergy.
Jenkins SG
Diagn Microbiol Infect Dis; 1989; 12(1):51-5. PubMed ID: 2714073
[TBL] [Abstract][Full Text] [Related]
11. Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions.
Giamarellou H
Am J Med; 1986 Jun; 80(6B):126-37. PubMed ID: 3088998
[TBL] [Abstract][Full Text] [Related]
12. Cefotaxime and desacetylcefotaxime in neonates and children: a review of microbiologic, pharmacokinetic, and clinical experience.
Jacobs RF; Kearns GL
Diagn Microbiol Infect Dis; 1989; 12(1):93-9. PubMed ID: 2653717
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
